Article
Low primary and secondary HIV drug-resistance after 12 months of antiretroviral therapy in human immune-deficiency virus type 1 (HIV-1)-infected individuals from Kigali, Rwanda.
PloS one - 1 Jan 2013
Rusine John, Asiimwe-Kateera Brenda, van de Wijgert Janneke, Boer Kimberly Rachel, Mukantwali Enatha, Karita Etienne, Gasengayire Agnes, Jurriaans Suzanne, de Jong Menno, Ondoa Pascale
Abstract excerpt
Treatment outcomes of HIV patients receiving antiretroviral therapy (ART) in Rwanda are scarcely documented. HIV viral load (VL) and HIV drug-resistance (HIVDR) outcomes at month 12 were determined in a prospective cohort study of antiretroviral-naïve HIV patients initiating first-line therapy in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.